Venous Angioplasty in Multiple Sclerosis

Original title: Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study. Reference: M Denislic et al. Phlebology, doi: 10.1258/phleb.2012.012065.

Multiple Sclerosis (MS) is considered a chronic inflammatory disease, progressive and immuno-mediated, demyelinating of the central nervous system. 

Its primary cause is still under debate and this study incorporates the vascular aetiology hypothesis. Restricted venous drainage is known as chronic cerebrospinal venous insufficiency (multiple sclerosis of the extracranial veins). The primary goal of this open trial was to detect the occurrence of obstruction in extracranial veins (internal jugular and azygos veins) and associate obstruction patterns with the clinical evolution and physical impairment of MS.

94 patients with MS diagnosis were evaluated and classified according to the three stages of the disease: relapsing/remitting (RR), secondary progressive (SP) and primary progressive (PP). Impairment degree was evaluated with the expanded disability status scale. All patients met at least two of the chronic cerebrospinal venous insufficiency criteria using intra and extracranial Doppler evaluation. Only in two patients (2.1%) venographies did not show any abnormalities. From the rest, 33.7% showed luminal compromise of the three veins and they all showed a compromised jugular. A >50% lesion was treated with balloon angioplasty. Balloon diameter started at 6 mm for the azygos vein and 7-8 mm for jugulars.

A neurological clinical follow up was performed using the disability scale. At 12 months, the group of patients at RR stage showed significative improvement of disability (p=0,001) compared to those at progressive stage (SP or PP) that did not improve. Restenosis using Doppler evaluation was 21.7%.

Conclusion 

The correlation between the number of vein lesions and impairment degree supports the vascular hypothesis. Angioplasty could be beneficial in the early stages of the disease.

Editorial Comment:

Though the number of patients was small, it might be difficult to carry out larger trials due to disease prevalence. The vascular aetiology hypothesis and angioplasty treatment of MS appear interesting in the present context of immunomodulatory therapy deficiency. 

http://solaci.org/es/pdfs/esclerosis_multiple.pdf
SOLACI.ORG

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...